For the management of neuromuscular disorders (NMD), subcutaneous immunoglobulin (SCIg) administration has become an alternate option, being a home-based alternative to conventional intravenous immunoglobulin (IVIg), with a comparable efficacy, minimum adverse effects and significant improvement to the quality of life. With the increased cost of healthcare management, it has become more challenging for clinicians and […]

Myasthenia gravis (MG) is caused by an immune attack on the nerve and muscles junctions and manifests as severe and sometimes life threatening muscle weakness. A number of effective immune modifying medications are available for MG. Intravenous immunoglobulin (IVIG) – a fraction of blood harvested from thousands of donors and containing high concentration of immunoglobulins, […]